Hear experts discuss the key considerations for tech transfer and present how a customized modeling tool can help streamline the scale-up of your oral small molecule program.
This week's Fierce LifeSci is brought to you by Catalent.
Date: Wednesday, January 27, 2021Time: 10am ET / 7am PTDuration: 1 Hour
The transition from early phase to late phase of a small molecule program plays a pivotal role in determining a program’s ultimate success. Join this webinar to hear experts discuss the key considerations for tech transfer and present how a customized modeling tool can help streamline the scale-up of your oral small molecule program.
Identification of critical material attributes (CMA), critical process parameter (CPP) and critical quality attributes (CQA) of drug product and how to predict their impact on a formulation and manufacturing processes
Overview of primary processing technology in OSD manufacturing and how material characteristics dictate the unit operations method.
